Back-up Plan Acne-Control Body Mist

Description

This formulation contains 2% salicylic acid, an active ingredient recognized for its efficacy in acne treatment. It is designed as a body mist, providing a convenient application method for acne control. The product is enhanced with tea tree oil and witch hazel, both known for their skin-soothing properties. The total volume of the product is 3 fluid ounces (100 milliliters).

Uses and Indications

This drug is indicated for the management of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The recommended administration involves spraying a thin layer to cover the entire affected area of the back. This application should occur one to three times daily, depending on the patient's needs and the physician's guidance.

To minimize the risk of excessive skin drying, it is advisable to initiate treatment with one application per day. The frequency may be gradually increased to two or three times daily as tolerated or as directed by a healthcare provider. In cases where bothersome dryness or peeling is observed, the application frequency should be reduced to once daily or every other day.

For new users, a sensitivity test is recommended. This involves applying the product sparingly to one or two small affected areas during the first three days of use. If no discomfort is experienced, the user may then proceed to follow the standard application instructions as outlined above.

Contraindications

Use of this product is contraindicated in the following situations:

• Spraying into the eyes is prohibited due to the potential for irritation or injury.

• Puncturing or incinerating the container is contraindicated to prevent risk of explosion or release of harmful substances.

• Storing the product at temperatures exceeding 120°F (50°C) is contraindicated as it may compromise the integrity of the formulation and lead to safety hazards.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients that the application of this product may lead to skin irritation and dryness, particularly if used concurrently with other topical acne medications. In cases where irritation occurs, it is recommended to limit the use to one topical acne medication at a time to minimize adverse effects.

Care should be taken to avoid contact with the eyes. The product is under pressure; therefore, it must not be punctured or incinerated. Additionally, it should not be stored at temperatures exceeding 120°F (50°C) to ensure safety and efficacy.

This product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Side Effects

Patients using this product may experience skin irritation and dryness, particularly if another topical acne medication is used concurrently. It is advised that only one topical acne medication be applied at a time to minimize the risk of irritation.

In addition, caution should be exercised to avoid spraying the product into the eyes, as this may lead to adverse effects. The product is under pressure; therefore, it should not be punctured or incinerated, and it must be stored at temperatures not exceeding 120°F (50°C).

In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately. This product is intended for external use only.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to alleviate symptoms. Monitoring for signs of skin irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Back-up Plan Acne-Control Body Mist (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is recommended.

For new users, a sensitivity test is advised. The product should be applied sparingly to one or two small affected areas during the first three days. If no discomfort occurs, patients may proceed with the standard application directions.

Geriatric Use

There is no specific information regarding the use of BACK-UP PLAN ACNE-CONTROL BODY MIST in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this product to elderly patients, as the absence of data necessitates careful consideration of individual patient factors and potential risks. Monitoring for any adverse effects is advisable in this population, given the lack of established guidelines for geriatric use.

Pregnancy

The safety of this product during pregnancy has not been established. Salicylic acid is contraindicated in pregnancy due to potential risks to the fetus, including the risk of teratogenic effects associated with its use. Pregnant women should avoid using this product unless directed by a healthcare provider. It is essential for healthcare professionals to counsel pregnant patients regarding these risks and to consider alternative treatment options when necessary.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of specific guidance when treating patients with renal impairment.

Hepatic Impairment

There is no available information regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the individual patient's liver status when prescribing this medication.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are advised to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's safety profile in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed that the use of this medication in conjunction with other topical acne treatments may increase the likelihood of skin irritation and dryness. It is recommended that patients use only one topical acne medication at a time to minimize the risk of irritation.

Additionally, healthcare providers should instruct patients to avoid spraying the medication into their eyes. Patients should be made aware that the contents are under pressure and should not be punctured or incinerated. It is also important to advise patients not to store the medication at temperatures exceeding 120°F (50°C).

Storage and Handling

The product is supplied in a container that is under pressure. It is essential to avoid storing the product at temperatures exceeding 120°F (50°C). Care should be taken to ensure that the container is not punctured or incinerated, as this may lead to hazardous situations. Proper handling and storage conditions are crucial to maintain the integrity and safety of the product.

Additional Clinical Information

The product is administered topically, with a recommended application of a thin layer sprayed over the entire affected area of the back one to three times daily. Clinicians should advise patients that the product is for external use only and caution against concurrent use with other topical acne medications, as this may increase the likelihood of skin irritation and dryness.

Patients should be instructed to avoid contact with the eyes and to be aware that the contents are under pressure; therefore, they should not puncture or incinerate the container and should store it at temperatures not exceeding 120°F (50°C). It is essential to keep the product out of reach of children, and in the event of ingestion, medical assistance or contact with a Poison Control Center is necessary. New users are encouraged to perform a sensitivity test by applying the product sparingly to one or two small affected areas during the first three days; if no discomfort occurs, they may proceed with the full application as directed.

Drug Information (PDF)

This file contains official product information for Back-up Plan Acne-Control Body Mist, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)